A double blind study on azathioprine efficacy in multiple sclerosis: final report

C. Milanese; L. La Mantia; A. Salmaggi; M. Eoli

doi:10.1007/BF00838165

A double blind study on azathioprine efficacy in multiple sclerosis: final report

C. Milanese, L. La Mantia, A. Salmaggi, M. Eoli

Fondazione IRCCS Istituto Neurologico "C. Besta"

Research output: Contribution to journal › Article › peer-review

Abstract

Forty patients, affected by multiple sclerosis with remitting-relapsing or progressive course, were included in a double blind study of treatment with azathioprine (2 mg/kg/day) lasting 3 years. The mean changes on the Expanded Disability Status Scale and in the survival analysis show a trend in favour of azathioprine both in slowing disease progression and reducing relapse frequency. These findings, repeatedly observed in similar trials, indicate that azathioprine should be used in the treatment of multiple sclerosis.

Original language	English
Pages (from-to)	295-298
Number of pages	4
Journal	Journal of Neurology
Volume	240
Issue number	5
DOIs	https://doi.org/10.1007/BF00838165
Publication status	Published - May 1993

Keywords

Azathioprine
Multiple sclerosis

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1007/BF00838165

Cite this

@article{172d3ba33acb4ead8f8797cee9a5a4da,

title = "A double blind study on azathioprine efficacy in multiple sclerosis: final report",

abstract = "Forty patients, affected by multiple sclerosis with remitting-relapsing or progressive course, were included in a double blind study of treatment with azathioprine (2 mg/kg/day) lasting 3 years. The mean changes on the Expanded Disability Status Scale and in the survival analysis show a trend in favour of azathioprine both in slowing disease progression and reducing relapse frequency. These findings, repeatedly observed in similar trials, indicate that azathioprine should be used in the treatment of multiple sclerosis.",

keywords = "Azathioprine, Multiple sclerosis",

author = "C. Milanese and {La Mantia}, L. and A. Salmaggi and M. Eoli",

year = "1993",

month = may,

doi = "10.1007/BF00838165",

language = "English",

volume = "240",

pages = "295--298",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",

number = "5",

}

TY - JOUR

T1 - A double blind study on azathioprine efficacy in multiple sclerosis

T2 - final report

AU - Milanese, C.

AU - La Mantia, L.

AU - Salmaggi, A.

AU - Eoli, M.

PY - 1993/5

Y1 - 1993/5

N2 - Forty patients, affected by multiple sclerosis with remitting-relapsing or progressive course, were included in a double blind study of treatment with azathioprine (2 mg/kg/day) lasting 3 years. The mean changes on the Expanded Disability Status Scale and in the survival analysis show a trend in favour of azathioprine both in slowing disease progression and reducing relapse frequency. These findings, repeatedly observed in similar trials, indicate that azathioprine should be used in the treatment of multiple sclerosis.

AB - Forty patients, affected by multiple sclerosis with remitting-relapsing or progressive course, were included in a double blind study of treatment with azathioprine (2 mg/kg/day) lasting 3 years. The mean changes on the Expanded Disability Status Scale and in the survival analysis show a trend in favour of azathioprine both in slowing disease progression and reducing relapse frequency. These findings, repeatedly observed in similar trials, indicate that azathioprine should be used in the treatment of multiple sclerosis.

KW - Azathioprine

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0027180925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027180925&partnerID=8YFLogxK

U2 - 10.1007/BF00838165

DO - 10.1007/BF00838165

M3 - Article

C2 - 8326334

AN - SCOPUS:0027180925

SN - 0340-5354

VL - 240

SP - 295

EP - 298

JO - Journal of Neurology

JF - Journal of Neurology

IS - 5

ER -

A double blind study on azathioprine efficacy in multiple sclerosis: final report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this